F.M. Delgado
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 2
- Neutropenia and Cancer Infections 1
-
- Breast Cancer Treatment Studies 8
- Co-authors
- P. FumoleauT. DelozierPierre KerbratM. NamerR KeilingAlain MonnierE García-GiraltMarie-Thérèse Closon
- Journals
- European Journal of Cancer (3 papers)Annals of Oncology (3 papers)Cancer (2 papers)British Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- FranceUnited KingdomSouth Africa
In The Last Decade
F.M. Delgado
19 papers receiving 781 citations
Peers
Comparison fields: 5 of 52
- Oncology 621
- Cancer Research 226
- Dermatology 87
- Pulmonary and Respiratory Medicine 220
- Genetics 67
Countries citing papers authored by F.M. Delgado
This map shows the geographic impact of F.M. Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.M. Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.M. Delgado more than expected).
Fields of papers citing papers by F.M. Delgado
This network shows the impact of papers produced by F.M. Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.M. Delgado. The network helps show where F.M. Delgado may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F.M. Delgado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 48 | |
| 2 | 2006 | 149 | |
| 3 | 2003 | 71 | |
| 4 | 1999 | 2 | |
| 5 | 1999 | 15 | |
| 6 | 1999 | 1 | |
| 7 | 1999 | 4 | |
| 8 | 1999 | 41 | |
| 9 | 1997 | 3 | |
| 10 | 1997 | 1 | |
| 11 | 1997 | 5 | |
| 12 | 1996 | 68 | |
| 13 | 1995 | 72 | |
| 14 | Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. | 1995 | 33 |
| 15 | 1993 | 281 | |
| 16 | [Size of breast cancer at the time of initial diagnosis]. | 1992 | 2 |
| 17 | 1991 | 6 | |
| 18 | 1989 | 2 | |
| 19 | 1988 | 6 |
About F.M. Delgado
F.M. Delgado is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pharmacology and Genetics, having authored 19 papers that have together received 810 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers), Advanced Breast Cancer Therapies (3 papers), Cancer therapeutics and mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Oncology (621 citations), Cancer Research (226 citations), Dermatology (87 citations), Pulmonary and Respiratory Medicine (220 citations) and Genetics (67 citations). F.M. Delgado has collaborated with scholars based in France, United Kingdom and South Africa. Frequent co-authors include P. Fumoleau, T. Delozier, Pierre Kerbrat, M. Namer, R Keiling, Alain Monnier, E García-Giralt, Marie-Thérèse Closon, Frédéric Rolland and Maria De Santis. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Cancer, British Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.